According to Sutro Biopharma's latest financial reports the company's current EPS (TTM) is -$4.24. In 2022 the company made an earnings per share (EPS) of -$4.07 a decrease over its 2021 EPS that were of -$3.93.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$4.02 | -1.28% |
2022 | -$4.07 | 3.49% |
2021 | -$3.93 | 78.91% |
2020 | -$2.20 | -47.11% |
2019 | -$4.15 | -12.2% |
2018 | -$4.73 |